Browsing Category

43911 posts

Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

The submission is supported by data from the pivotal WU-KONG1 Part B…

ZKH Group Limited to Announce Third Quarter 2024 Financial Results on Friday, November 22, 2024

SHANGHAI, Nov. 8, 2024 /PRNewswire/ — ZKH Group Limited ("ZKH" or the…

Global Times: World Conference of Classics creates new platform for mutual learning

BEIJING, Nov. 8, 2024 /PRNewswire/ — Chinese President Xi Jinping sent a…
Nansha Shines at CIIE: Converging at the Bay, Connecting to the World

Nansha Shines at CIIE: Converging at the Bay, Connecting to the World

SHANGHAI, Nov. 8, 2024 /PRNewswire/ — This is a news release from Nansha…
Nansha Shines at CIIE: Converging at the Bay, Connecting to the World

Nansha Shines at CIIE: Converging at the Bay, Connecting to the World

SHANGHAI, Nov. 8, 2024 /PRNewswire/ — This is a news release from…

Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 8, 2024 /PRNewswire/ — Harbour…

Goodbaby International Holdings Limited Announces Revenue Performance for The Nine Months Ended 30 September 2024

Group Revenue Achieves Double-Digit Growth CYBEX Sets Another Revenue Record  HONG KONG,…
ZTE hosts 5G Summit & User Congress 2024 in Türkiye, showcasing the digital future under the theme "Flourish Through Intelligent Innovation"

ZTE hosts 5G Summit & User Congress 2024 in Türkiye, showcasing the digital future under the theme "Flourish Through Intelligent Innovation"

ISTANBUL, Nov. 8, 2024 /PRNewswire/ — ZTE Corporation (0763.HK / 000063.SZ), a…